Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2565K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Jacquenet, S.
Right arrow Articles by Branlant, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacquenet, S.
Right arrow Articles by Branlant, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2001, Vol. 29, No. 2 464-478
© 2001 Oxford University Press

Conserved stem–loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing

Sandrine Jacquenet, Delphine Ropers, Patricia S. Bilodeau1, Laurence Damier, Annie Mougin, C. Martin Stoltzfus1 and Christiane Branlant*

Laboratoire de Maturation des ARN et Enzymologie Moléculaire, UMR 7567 UHP-CNRS, Université Henri Poincaré Nancy 1, Boulevard des Aiguillettes, BP239, 54506 Vandoeuvre-lès-Nancy cedex, France and 1Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA

The HIV-1 transcript is alternatively spliced to over 30 different mRNAs. Whether RNA secondary structure can influence HIV-1 RNA alternative splicing has not previously been examined. Here we have determined the secondary structure of the HIV-1/BRU RNA segment, containing the alternative A3, A4a, A4b, A4c and A5 3' splice sites. Site A3, required for tat mRNA production, is contained in the terminal loop of a stem–loop structure (SLS2), which is highly conserved in HIV-1 and related SIVcpz strains. The exon splicing silencer (ESS2) acting on site A3 is located in a long irregular stem–loop structure (SLS3). Two SLS3 domains were protected by nuclear components under splicing condition assays. One contains the A4c branch points and a putative SR protein binding site. The other one is adjacent to ESS2. Unexpectedly, only the 3' A residue of ESS2 was protected. The suboptimal A3 polypyrimidine tract (PPT) is base paired. Using site-directed mutagenesis and transfection of a mini-HIV-1 cDNA into HeLa cells, we found that, in a wild-type PPT context, a mutation of the A3 downstream sequence that reinforced SLS2 stability decreased site A3 utilization. This was not the case with an optimized PPT. Hence, sequence and secondary structure of the PPT may cooperate in limiting site A3 utilization.

* To whom correspondence should be addressed. Tel: +33 3 83 91 20 91; Fax: +33 3 83 91 20 93; Email: christiane.branlant{at}maem.uhp-nancy.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
J. A. Jablonski, E. Buratti, C. Stuani, and M. Caputi
The Secondary Structure of the Human Immunodeficiency Virus Type 1 Transcript Modulates Viral Splicing and Infectivity
J. Virol., August 15, 2008; 82(16): 8038 - 8050.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. E. M. Abbink and B. Berkhout
RNA Structure Modulates Splicing Efficiency at the Human Immunodeficiency Virus Type 1 Major Splice Donor
J. Virol., March 15, 2008; 82(6): 3090 - 3098.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. N. Singh, R. N. Singh, and E. J. Androphy
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Nucleic Acids Res., January 28, 2007; 35(2): 371 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hallay, N. Locker, L. Ayadi, D. Ropers, E. Guittet, and C. Branlant
Biochemical and NMR Study on the Competition between Proteins SC35, SRp40, and Heterogeneous Nuclear Ribonucleoprotein A1 at the HIV-1 Tat Exon 2 Splicing Site
J. Biol. Chem., December 1, 2006; 281(48): 37159 - 37174.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Madsen and C. M. Stoltzfus
An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication
J. Virol., August 15, 2005; 79(16): 10478 - 10486.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
Y. Lian and H. R. Garner
Evidence for the regulation of alternative splicing via complementary DNA sequence repeats
Bioinformatics, April 15, 2005; 21(8): 1358 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Buratti and F. E. Baralle
Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process
Mol. Cell. Biol., December 15, 2004; 24(24): 10505 - 10514.
[Full Text] [PDF]


Home page
RNAHome page
J. CABELLO-VILLEGAS, K. E. GILES, A. M. SOTO, P. YU, A. MOUGIN, K. L. BEEMON, and Y.-X. WANG
Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor
RNA, September 1, 2004; 10(9): 1388 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Ropers, L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant, and J. Stevenin
Differential Effects of the SR Proteins 9G8, SC35, ASF/SF2, and SRp40 on the Utilization of the A1 to A5 Splicing Sites of HIV-1 RNA
J. Biol. Chem., July 16, 2004; 279(29): 29963 - 29973.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Buratti, A. F. Muro, M. Giombi, D. Gherbassi, A. Iaconcig, and F. E. Baralle
RNA Folding Affects the Recruitment of SR Proteins by Mouse and Human Polypurinic Enhancer Elements in the Fibronectin EDA Exon
Mol. Cell. Biol., February 1, 2004; 24(3): 1387 - 1400.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. K. Domsic, Y. Wang, A. Mayeda, A. R. Krainer, and C. M. Stoltzfus
Human Immunodeficiency Virus Type 1 hnRNP A/B-Dependent Exonic Splicing Silencer ESSV Antagonizes Binding of U2AF65 to Viral Polypyrimidine Tracts
Mol. Cell. Biol., December 1, 2003; 23(23): 8762 - 8772.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Freund, C. Asang, S. Kammler, C. Konermann, J. Krummheuer, M. Hipp, I. Meyer, W. Gierling, S. Theiss, T. Preuss, et al.
A novel approach to describe a U1 snRNA binding site
Nucleic Acids Res., December 1, 2003; 31(23): 6963 - 6975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Muh, R. H. Hovhannisyan, and R. P. Carstens
A Non-sequence-specific Double-stranded RNA Structural Element Regulates Splicing of Two Mutually Exclusive Exons of Fibroblast Growth Factor Receptor 2 (FGFR2)
J. Biol. Chem., December 13, 2002; 277(51): 50143 - 50154.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Roy, J.-S. Paquette, J.-F. Fortin, and M. J. Tremblay
The Immunosuppressant Rapamycin Represses Human Immunodeficiency Virus Type 1 Replication
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3447 - 3455.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. S. Bilodeau, J. K. Domsic, A. Mayeda, A. R. Krainer, and C. M. Stoltzfus
RNA Splicing at Human Immunodeficiency Virus Type 1 3' Splice Site A2 Is Regulated by Binding of hnRNP A/B Proteins to an Exonic Splicing Silencer Element
J. Virol., September 15, 2001; 75(18): 8487 - 8497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jacquenet, A. Mereau, P. S. Bilodeau, L. Damier, C. M. Stoltzfus, and C. Branlant
A Second Exon Splicing Silencer within Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H
J. Biol. Chem., October 26, 2001; 276(44): 40464 - 40475.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.